Citadel Advisors - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 46 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2015. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q3 2016$160,000
-57.4%
229,258
+21.4%
0.00%
Q2 2016$376,000
-17.9%
188,851
-0.7%
0.00%
-100.0%
Q1 2016$458,000
-73.1%
190,177
-14.3%
0.00%
-50.0%
Q4 2015$1,701,000
+55.9%
221,821
+7.6%
0.00%
+100.0%
Q3 2015$1,091,000
+2437.2%
206,225
+4183.9%
0.00%
Q2 2015$43,000
+19.4%
4,814
-14.9%
0.00%
Q1 2015$36,000
+350.0%
5,658
+289.7%
0.00%
Q4 2014$8,000
-96.7%
1,452
-93.7%
0.00%
Q1 2014$240,00023,0800.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2015
NameSharesValueWeighting ↓
FNY Managed Accounts LLC 75,000$35,258,0000.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 696,455$327,0000.02%
Klingman & Associates, LLC 10,000$5,0000.00%
BLUESTEIN R H & CO LLC 76,500$36,0000.00%
OPPENHEIMER & CO INC 73,500$34,0000.00%
Renaissance Technologies 774,603$364,0000.00%
Walleye Trading LLC 6$00.00%
Bank of New York Mellon Corp 16,660$8,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11,071$5,0000.00%
SIMPLEX TRADING, LLC 200$00.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders